Introduction
Polyploidy describes the condition of having more than two sets of chromosomes. Unlike organisms such as fish and amphibians, polyploidization is poorly tolerated in mammals. Only a handful of tetraploid human infants have ever been documented. 1 While rereplication is stringently prevented in most cells, polyploidy occurs physiologically in specialized cell types, such as myoblasts, megakaryocytes, trophoblasts and hepatocytes. 2 Most of these cases involve fusion or endoreduplication of terminally differentiated cells. Cancer cells, however, are frequently characterized by polyploidization. 3 Therefore an interesting approach of anticancer therapies is to exploit this increased DNA contents of cancer cells.
A growing body of evidence indicates that polyploidization can initiate chromosomal instability and neoplastic transformation. 3 In his seminal work, Ohno proposed that whole-genome duplication provides the primary source of redundant genes for new evolutionary opportunities. 4 The multistep progression of cancer, including initiation, progression, heterogeneity and drug resistance, is also a product of evolutionary processes. 5 The extra sets of chromosomes after polyploidization may act as a reservoir of genetic materials to allow clonal evolution of tumors.
Mechanisms including cell fusion, mitotic slippage and cytokinesis failure are the main causes of tetraploidy. 6, 7 The newly formed tetraploid cells are often genetically unstable due to supernumerary centrosomes and amplified chromosomes. Indeed, tetraploid cells are commonly found in early stages of tumors, such Aurora kinases are overexpressed in many cancers and are targets for anticancer drugs. the yeast homolog of Aurora B kinase, IPL1, was found to be a ploidy-specific lethality gene. Given that polyploidization is a common feature of many cancers, we hypothesized polyploidization also sensitizes mammalian cells to inhibition of Aurora kinases. Using two models of apparent diploid vs. tetraploid cell lines (one based on the hepatocellular carcinoma cell line Hep3B and another on untransformed mouse fibroblasts), we found that tetraploid cells were more sensitive to Aurora B inhibition than their diploid counterparts. Apoptosis could be induced in tetraploid cells by two different Aurora B inhibitors. Furthermore, tetraploid cells were sensitive to Aurora B inhibition but were not affected by Aurora A inhibition. Interestingly, the underlying mechanism was due to mitotic slippage and the subsequent excessive genome reduplication. In support of this, abolition of cytokinesis with dihydrocytochalasin B resulted in similar effects on tetraploid cells as Aurora B inhibition. these results indicate that inhibition of Aurora B or cytokinesis can promote apoptosis effectively in polyploid cancer cells. Keywords: aurora kinases, cancer, cell cycle, mitosis, tetraploidy as Barrett esophagus 8, 9 and cervical carcinoma. 10 Moreover, evidence from transformation of mouse epithelial cells also indicates the appearance of tetraploid cells before they undergo a period of chromosome instability. 11 Several processes that cause tetraploidization, including chromosome nondisjunction (which promotes cleavage furrow regression), 12 persistent telomere damage 13 and virus-mediated cell fusion, 14 have been implicated in tumorigenesis. Finally, tetraploids generated by transiently blocking cytokinesis in p53-null mouse mammary epithelial cells can trigger tumor formation after injection into nude mice. 15 After tetraploidization, the unequal segregation of chromosomes during the subsequent multipolar mitosis probably leads to p53-dependent apoptosis, thereby suppressing tumorigenesis. Interestingly, p53 does not appear to be essential for maintaining chromosome stability once stable tetraploids are established. 16 These and other studies provide strong evidence of the importance of tetraploidization as an early step in tumorigenesis.
Tetraploidization increases sensitivity to Aurora B kinase inhibition
Maintaining a tetraploidy state requires profound changes in cellular physiology. Using a yeast screen designed to identify ploidy-specific lethality genes, Storchova et al. discovered that a small group of genes is required for tetraploid yeast cells to maintain viability.
17 IPL1, the yeast ortholog of Aurora B kinase, was found to be essential for survival of tetraploid cells.
Accurate separation of a cell into two new daughter cells relies on a well-balanced regulating network of kinases and phosphatases. 18 One important family of mitotic kinases is the Aurora kinases. While budding yeast contains a single Aurora kinase (Ipl1p, which is a functional homolog of Aurora B), mammals Downloaded by [58.32.204 .170] at 18:00 23 November 2015 G 2 /M DNA was induced after cells were treated with ZM447439 for 48 h (Fig. 1A) . Moreover, a portion of the cells underwent mitotic slippage and genome reduplication, as indicated by the appearance of cells containing higher DNA contents than normal G 2 /M.
Treatment of Hep3B and Hep3B-T cells with ZM447439 induced apoptosis, as indicated by the cleavage of the caspase substrate PARP (Fig. 1B) . We noted that treatment with ZM447439 for 48 h induced more sub-G 1 population in Hep3B-T than Hep3B (Fig. 1A) . Direct quantification of cell number after trypan blue staining also confirmed that AURKB inhibition exerted a stronger anti-proliferation effect on Hep3B-T than on Hep3B (Fig. 1C) . The differential sensitivity of Hep3B and Hep3B-T to AURKB inhibition was not due to their different unperturbed growth rates, because both cell lines have similar doubling time. 23 To verify the relative cytotoxicity of ZM447439 on Hep3B and Hep3B-T, the cells were incubated with the AURKB inhibitor for 72 h. Analysis using trypan blue exclusion staining indicated that the cell number was reduced more pronouncedly in Hep3B-T than in Hep3B (Fig. 1D) . Flow cytometry analysis also showed significantly more cell death in Hep3B-T than in Hep3B (Fig. 1E) . Consistent with apoptotic cell death, the amount of ZM447439-mediated sub-G 1 cells was markedly reduced in the presence of a pan-caspase inhibitor. Collectively, these data suggest that AURKB inhibition triggers more extensive apoptotic cell death in tetraploid cells than in their diploid counterparts.
Tetraploid cells are sensitized by inhibition of AURKB but not AURKA. Given that Hep3B-T appears to be more sensitive to the AURKB inhibitor ZM447439 than Hep3B, we next validated these findings by using a different Aurora kinase inhibitor. The small molecule MLN8237 is believed to be a specific inhibitor of AURKA. 22, 25 In fact, we found that MLN8237 inhibited both AURKA and AURKB in a concentration-dependent manner. Activation of AURKA and AURKB during mitosis is associated with the phosphorylation of a key threonine residue at the activation loop (Thr288 in AURKA and Thr232 in AURKB 26, 27 ). Only the phosphorylation of AURKA Thr288 was inhibited at relatively low concentrations of MLN8237 (0.1-0.5 μM). In contrast, phosphorylation of both AURKA Thr288 and AURKB Thr232 was abolished at higher concentrations of MLN8237 ( Fig. 2A) . These results indicate that, at low concentrations, MLN8237 served as a specific AURKA inhibitor, but both AURKA and AURKB were targeted at higher concentrations of MLN8237. Using time-lapse microscopy, we tracked the fate of individual cells after MLN8237 challenge (Fig. 2B) . Although the duration of mitosis was extended after treatment with both low (0.1 μM) and high (0.75 μM) concentrations of MLN8237 (quantified in Fig. 2C ), mitotic slippage without cytokinesis was promoted only after treatment with the high concentration of MLN8237 (quantified in Fig. 2D ). Representative videos of mitosis in control Hep3B (Video 1) and Hep3B-T (Video 2) as well as MLN8237-treated Hep3B (Video 3) and Hep3B-T (Video 4) are shown in the Supplemental Material. These data are consistent with the idea that while low concentrations of MLN8237 mainly inhibited AURKA, higher concentrations also inhibited AURKB. contain three homologs that display unique functions during mitosis. Aurora A (AURKA) is a centrosome protein involved in the maturation and separation of centrosomes and the formation of a bipolar spindle. Aurora B (AURKB), on the other hand, is a component of the chromosomal passenger complex (CPC). CPC localizes to chromosomes and kinetochores in early mitosis and is responsible for releasing incorrect microtubule-kinetochore connections. In anaphase, the CPC is relocated to the mid-zone to promote cytokinesis. 19 The role of the last family member, Aurora C (AURKC), which is mainly expressed in testis, is not wellcharacterized. 20, 21 All three Aurora kinases are overexpressed in many types of cancers and are believed to be important targets for anticancer drugs currently at various stages of clinical trials. 22 Based on the fact that Aurora B (IPL1) was identified as a ploidy-specific lethality gene in yeast, and that tetraploidization is a common feature of many cancers, we hypothesized that tetraploid mammalian cells may also be more sensitive to inhibition of Aurora kinases than diploid cells. We utilized two models of apparent diploid vs. tetraploid cell lines to test if tetraploidization sensitizes cells to Aurora kinase inhibition. We found that tetraploid cells were more sensitive to Aurora kinase inhibitors than their diploid counterparts. Interestingly, the underlying mechanism was due to the abolition of cytokinesis and the subsequent excessive genome reduplication.
Results
The tetraploid cell line Hep3B-T is more sensitive to AURKB inhibitors than Hep3B. To study the sensitivity of tetraploid mammalian cells to AURKB inhibition, a fundamental prerequisite is to be able to compare diploid and tetraploid cells from the same lineage. In a previous study, we found that the cell line Hep3B lacks the mechanisms that prevent mitotic slippage and genome reduplication after spindle disruption. Moreover, when Hep3B cells were treated with nocodazole for 48 h before allowing them to recover in nocodazole-free medium, the surviving cells were found to contain double the DNA content of the parental Hep3B cells (designated as Hep3B-T). 23 As revealed by both flow cytometry analysis and direct chromosomes counting, the tetraploid DNA contents of Hep3B-T was stable for at least 10 generations.
We made use of Hep3B and Hep3B-T to examine if tetraploidization affects cell survival after AURKB is inhibited. Analysis of the DNA contents with flow cytometry confirmed that Hep3B-T contained roughly double the DNA of Hep3B (Fig.  1A) . As expected, depletion of AURKB with siRNA enriched cells in G 2 /M in both Hep3B and Hep3B-T. The knockdown efficiency of AURKB in both cell lines was assessed by immunoblotting (Fig. 1B) . However, targeting AURKB with siRNA was only partially effective in disrupting mitosis and cytokinesis (as revealed by live cell imaging, data not shown), probably due to the presence of residual AURKB. This is also reflected in the incomplete trap of cells in G 2 /M as indicated by flow cytometry (Fig. 1A) . To achieve a more complete inhibition of AURKB, chemical inhibitors of Aurora kinases, including ZM447439, © 2012 Landes Bioscience.
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Cell Cycleinhibited AURKB. Importantly, substantially more apoptosis was triggered by MLN8237 in Hep3B-T than in Hep3B. Taken together, these experiments with MLN8237 indicate that, similar to the conclusion from using ZM447439, Hep3B-T are more sensitive to AURKB inhibition than Hep3B. Moreover, apoptosis was only induced with concentrations of MLN8237
We next treated both Hep3B and Hep3B-T cells with different concentrations of MLN8237 and analyzed the cell cycle profiles after 48 h (Fig. 3) . At concentrations that inhibited AURKA, MLN8237 mainly induced G 2 /M enrichment with little sign of cell death. In contrast, a significant sub-G 1 population was induced with the higher concentrations of MLN8237 that also Figure 1 . the tetraploid cell line Hep3B-t is more sensitive to AURKB inhibition than Hep3B. (A) AURKB inhibition induces cell cycle arrest followed by genome reduplication in both Hep3B and Hep3B-t cells. Cells were mock-treated, transfected with siRNA against AURKB (siAURKB), or treated with the AURKB inhibitor ZM447439. After incubation of 48 h, the cells were fixed and analyzed with flow cytometry. the positions of DNA contents up to 16N (relative to Hep3B) are indicated. Hep3B-t contained roughly double the DNA of Hep3B (the position of the G 1 peak of Hep3B-t is at a similar position as the G 2 /M peak in Hep3B). (B) Confirmation of siRNA-mediated depletion of AURKB. Hep3B and Hep3B-t cells were treated with AURKB siRNA or ZM447439. After 48 h, lysates were prepared and the expression of AURKB and cleaved pARp was analyzed by immunoblotting. equal loading was confirmed by probing for actin. (C) AURKB inhibition exerts a significant anti-proliferation effect on tetraploid cells. Hep3B and Hep3B-t cells were treated with AURKB siRNA and ZM447439. After 48 h, cell number was quantified with trypan blue analysis. (D) Hep3Bt are more sensitive to AURKB inhibitor than Hep3B. Hep3B and Hep3B-t cells were treated with either buffer or ZM447439. At 72 h, the cell number was quantified with trypan blue analysis. the mean and SD of three independent experiments are shown. (e) AURKB inhibitor induces more sub-G 1 population in Hep3Bt than in Hep3B. Hep3B and Hep3B-t cells were treated with either buffer or ZM447439 in the presence or absence of a pan-caspase inhibitor Z-VAD(oMe)-FMK. At 72 h, the cells were fixed and analyzed with flow cytometry.
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www.landesbioscience.com Cell Cyclethat inhibit AURKB but not with concentrations that inhibit AURKA alone. Tetraploid mouse fibroblasts are more sensitive to AURKB inhibition than diploid mouse fibroblasts. To ensure that the sensitivity of tetraploid cells to AURKB inhibitors is not limited to the Hep3B/Hep3B-T model, we tested a second model of diploid/tetraploid cell lines based on mouse fibroblasts. In a previous study, we generated an apparent tetraploid cell line by polyethylene glycol-mediated cell fusion. Swiss 3T3 fibroblasts containing blasticidin-or G418-resistant genes were first generated. Cell-cell fusion was then performed between serum-starved blasticidinand G418-resistant cells. Cells selected with both blasticidin and G418 (designated as 3T3-fusion) were found to be tetraploid in comparison to the parental Swiss 3T3. 16 Both the 3T3-fusion and parental 3T3 cells were treated with ZM447439 for 72 h before being harvested. Trypan blue counting indicated that ZM447439 triggered more cell death in the tetraploid 3T3-fusion than the diploid 3T3 (Fig. 4A) . Flow cytometry analysis also indicated that 3T3-fusion underwent more extensive cell death after AURKB inhibition than 3T3 (Fig. 4B) . The sub-G 1 population could be reduced with caspase inhibitors, confirming that ZM447439 triggered apoptosis in the 3T3-fusion cells (Fig. 4C) . These experiments also verified that 3T3-fusion contained roughly doubled the DNA content as 3T3. As observed for Hep3B/Hep3B-T, the fibroblasts underwent whole-genome reduplication after treatment with the AURKB inhibitor. To complement these findings, we also examined early apoptotic events by examining cleavage of PARP. In agreement with other results, ZM447439 triggered PARP cleavage more robustly in 3T3-fusion than in 3T3 (Fig. 4D) .
To make sure that the differential effects of the AURKB inhibitor on diploid vs. tetraploid cells was not simply due to the difference in AURKB expression, we next directly compared the expression of AURKB in the two cell lines. Immunoblotting analysis indicated similar expression of AURKB in 3T3 and 3T3-fusion (Fig. 4E) . Likewise, the expression of AURKB in Hep3B and Hep3B-T was also comparable (Fig. 1B) . Taken together, these results indicate that in agreement with Hep3B/ Hep3B-T model, tetraploid mouse fibroblasts are more sensitive to AURKB inhibition than the diploid fibroblasts.
The sensitivity of tetraploid cells to AURKB inhibition is caused by the abolition of cytokinesis and excessive genome To obtain evidence of this hypothesis, we investigated if the ploidy could be increased further if cell death is inhibited after treatment with AURKB inhibitors (Fig. 5A) . HeLa cells treated with ZM447439 for 24 h contained mainly 4N DNA. A population with higher DNA contents up to 8N was also present, indicating that whole-genome reduplication had been initiated. Massive cell death was induced at later time points. As expected, suppression of ZM447439-mediated apoptosis with caspase inhibitors reduced the sub-G 1 population. Importantly, cells with higher DNA contents (up to 16 N) appeared when apoptosis was suppressed. One interpretation of these data is that the apoptotic cells were mainly derived from cells with 16N DNA contents, reduplication. Why are tetraploids more sensitive to AURKB inhibitors than diploids? The higher DNA contents of tetraploids could have a direct effect on the sensitivity to AURKB inhibitors. We think this is unlikely to be the mechanistic basis, because apoptosis typically did not occur immediately, occurring only following rounds of genome reduplication. As the inhibition of AURKB leads to genome reduplication, we hypothesized that there is a limit on the DNA contents before cells cannot maintain their physiology properly and undergo apoptosis. The higher DNA content of tetraploids simply allows them to reach the critical DNA contents quicker, thereby predisposing them to a higher sensitivity to AURKB inhibition. 
www.landesbioscience.com Cell Cyclestability. 17 They can be divided into three functional groups involved in homologous recombination, sister chromatid cohesion and mitotic spindle function. Proteins encoded by the third group of genes include those that function in the spindle-assembly checkpoint (Bub1p and Bub3p), microtubule plus-end-associated proteins (Bik1p, Bim1p and Stu2p), a kinesin-like motor protein (Kar3p), components of the spindle pole body as well as the yeast homologous of AURKB, Ipl1p.
We have examined the effects of AURKB inhibition using two models of apparent diploid vs. tetraploid mammalian cell lines. Our main conclusion is that AURKB inhibitors triggered suggesting that apoptosis induced by AURKB inhibition may be caused by excessive replication of DNA.
To further test the hypothesis, we repeated the above experiment using another chemical that did not target AURKB but could still trigger genome reduplication. Cells were incubated with dihydrocytochalasin B (DCB), a drug that interferes with actin assembly, to inhibit cytokinesis. Flow cytometry analysis confirmed that DCB-treated cells displayed 4N and 8N DNA contents after 24 h and 48 h (Fig. 5B) . Massive cell death was induced after 72 h of DCB treatment. Suppression of apoptosis with caspase inhibitors led to a concomitant increase in cells with higher DNA contents (up to 16 N). It is noteworthy that DCB appeared to induce genome reduplication slower than ZM447439, which may explain why apoptosis was also delayed. These data indicate that inhibition of cytokinesis recapitulates the genome reduplication and apoptosis induced by AURKB inhibition.
To ensure that the effects of ZM447439 on genome reduplication was specific for AURKB, we generated a HeLa cell line that overexpressed EGFP-tagged AURKB (Fig. 6A) . Compared with the parental HeLa cells, the AURKB-overexpressing cells were less sensitive to the same concentrations of ZM447439 (Fig. 6B) . Both genome reduplication and apoptosis were reduced in the AURKB-overexpressing cells, supporting that the majority of the ZM447439-mediated effects were caused by AURKB.
Given that DCB promoted genome reduplication and cell death similarly to the AURKB inhibitors, we next tested if tetraploids are also more sensitive to DCB treatment than diploids. Indeed, Hep3B-T cells treated with DCB underwent more extensive apoptosis than Hep3B cells (Fig. 7A) . Likewise, 3T3-fusion cells were more sensitive to DCB than the diploid 3T3 cells (Fig. 7B) .
Collectively, these data reveal that DCB recapitulates the effects of AURKB inhibitors on tetraploid cells. The sensitivity of tetraploid cells to AURKB inhibition is likely to be caused by the abolition of cytokinesis and excessive genome reduplication.
Discussion
A relatively small number of genes were identified to be specifically required for tetraploid yeast cells to maintain genome Both pairs of diploid vs. tetraploid-Hep3B vs. Hep3B-T (Fig.  1B) and 3T3 vs. 3T3-fusion (Fig. 4E) -contained similar levels of AURKB, indicating that the differences in sensitivity to AURKB inhibitors were not simply due to the levels of the target.
Several types of experiments indicated that the cell death induced by AURKB inhibitors in tetraploid cells was due to apoptosis. In addition to the appearance of classic apoptotic cell morphology (data not shown), the induction of PARP cleavage (Figs. 1B and 4D) , sub-G 1 population (Fig. 1E) and the inhibition of cell death by caspase inhibitors (Fig. 1E) all supported an apoptotic mode of cell death after treatment with AURKB inhibitors.
Similar results were obtained with two different Aurora kinase inhibitors, ZM447439 (Fig. 1E) and MLN8237 (Fig. 3) . While ZM447439 belongs to an earlier generation of Aurora kinase inhibitors, MLN8237 is a newer generation of drug that is undergoing phase I and phase II clinical trials. 22 Due to their high sequence similarity, it is challenging to develop inhibitors specific for individual Aurora kinases. ZM447439 inhibited both AURKA and AURKB. Differential inhibition of the two kinases could be achieved by ZM447439 only over a very narrow range of concentrations (our unpublished data). In contrast, while low concentrations of MLN8237 inhibited AURKA only, both AURKA and AURKB were inhibited at higher concentrations of MLN8237 (Fig. 2A) . The selective inhibition of AURKA and AURKB by MLN8237 was also confirmed by the induction of mitotic delay and mitotic slippage at low and high concentrations of MLN8237, respectively (Fig. 2B) . Using the different concentrations of MLN8237, we found that tetraploid cells were sensitized by inhibition of AURKB but not AURKA (Fig. 3) .
It should be noted that as the available AURKB inhibitors also inhibited AURKA, we cannot rule out the possibility that the inhibition of both AURKA and AURKB was involved in killing tetraploid cells. Nevertheless, AURKB-specific sensitization of tetraploid cells was supported by experiments using siRNAmediated depletion (Fig. 1C) . Furthermore, overexpression of AURKB reduced the extent of cell death triggered by ZM447439 (Fig. 6B) .
We believe that the cell death induced by treatment with AURKB inhibitors was mainly due to excessive genome reduplication. As AURKB inhibitors induced mitotic slippage without chromosome segregation and cytokinesis, the genome could undergo multiple rounds of reduplication (Fig. 5A) . In the continuous presence of AURKB inhibitors, cell death was triggered by an increase in DNA contents without intervening mitosis. This idea is supported by recapitulating the effects of AURKB inhibitors on tetraploid cells using DCB (Fig. 7) . Note that this mechanism may differ from situations when cells are challenged with AURKB inhibitors transiently. The subsequent multipolar mitosis after mitotic slippage can promote unequal distribution of chromosomes into the daughter cells, which results in cell death or genome instability.
Interestingly, cell death occurred in AURKB inhibitor-treated HeLa (Fig. 5) , 3T3-fusion (Fig. 4B) and Hep3B-T cells (Fig. 1E) after the DNA contents reached 16N (relative to the diploid of the parental cell lines). One possibility is that cells were able to more extensive apoptotic cell death in tetraploid Hep3B-T and 3T3-fusion cells than in their diploid counterparts. It should be noted that while Hep3B is a cell line derived from hepatocellular carcinoma, both 3T3 and 3T3-fusion are non-transformed mouse fibroblasts, unable to form colonies on soft agar or induce tumor when injected into nude mice. 16 These results suggest that increased sensitivity to AURKB inhibitors was probably caused by tetraploidization and was independent on transformation. 
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Cell Cyclemaintain their functions after two rounds of reduplication, but they were unable to tolerate ploidy in excess of 16N. As tetraploid cells started with double the DNA contents as diploid cells, they reached this ploidy limit more readily than their diploid counterparts. Consequently, this may account for the increased sensitivity of tetraploid cells to AURKB inhibitors. We can only speculate what factors limit the amount of DNA that cells can tolerate. Cell volume, which is proportional to the DNA contents, could be a critical factor. As cells increase in size, physical limits of molecular transport and signaling may undermine survival. Specialized cell types that are physiologically capable of containing large amount of DNA, such as megakaryocytes, may possess mechanisms to prevent apoptosis at large cell volume.
Products of several genes identified in the yeast ploidy-specific lethality screen, such as Ipl1p, are involved in sensing tension across kinetochores and releasing incorrectly attached microtubules. 17 Storchova et al. reasoned that the increased demand for this specific group of proteins is due to the high frequency of syntelic or monotelic kinetochore-microtubule attachments in tetraploid cells. A possible explanation for the elevated number of incorrect microtubule-kinetochore attachments is the alteration in spindle geometry. While the microtubule length is unaffected by an increase in ploidy, the size of the spindle pole body and the number of spindles roughly doubled, causing an altered spindle geometry and, consequently, attachment defects. In this regard, the underlying mechanism of the selective sensitivity of tetraploid mammalian cells to AURKB inhibitors differed from that of the yeast gene disruption studies. Nevertheless, the findings of the increased sensitivity of tetraploid cancer cells to Aurora kinase inhibitors may provide an opportunity for developing anticancer therapies.
In conclusion, our data indicate that inhibition of AURKB induces stronger apoptotic responses in tetraploid than diploid cells. The underlying mechanism was likely to be due to mitotic slippage and the subsequent excessive genome reduplication.
Materials and Methods
DNA constructs. The AURKB cDNA sequence was amplified by PCR using the oligonucleotides 5'-CTG GGC CCA TGG CCC AGA AGG AGA ACT-3' and 5'-AGG GGC CCG GCG ACA GAT TGA AGG GC-3'. The PCR product was cut with Apa I and ligated into FLAG-EGFP in pUHD-P3T 28 to obtain FLAG-AURKB-EGFP in pUHD-P3T. The histone H2B cDNA sequence was amplified by PCR using the oligonucleotides 5'-TAC CGC TAG CAT GCC AGA GCC AGC GAA-3' and 5'-TAC CGC TAG CAT GCC AGA GCC AGC GAA-3'. The PCR product was digested with Nhe I and ligated into pcDNA3.1(-) (Invitrogen). The CMV promoter and the histone H2B-mRFP sequence were released with BglII and Xho I, ligated into pRevTRE2 (Clontech) to generate histone H2B-mRFP in pRevTRE2.
Cell culture. Swiss3T3 (mouse fibroblasts) and Hep3B (hepatocellular carcinoma) were obtained from the American Type Culture Collection. Tetraploid cell lines derived from Swiss3T3 (3T3-fusion) 16 and Hep3B (Hep3B-T) 23 were generated in our laboratory as described previously. The HeLa cell line used in this study is a clone that expressed the Tet-Off tetracycline repressor chimera. 29 Cells were propagated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) calf serum (for HeLa) or fetal bovine serum (for other cells) (Invitrogen) and 50 U/ml penicillin-streptomycin (Invitrogen) in a humidified incubator at 37°C in 5% CO 2 . To generate cell lines expressing FLAG-AURKB-EGFP, HeLa cells stably expressing histone H2B-mRFP were co-transfected with the FLAG-AURKB-EGFP in pUHD-P3T and a plasmid expressing PUR-resistant gene. antibodies against AURKA (BD Biosciences), rabbit polyclonal antibodies against AURKB (Sigma-Aldrich), rabbit polyclonal antibodies against AURKC (Invitrogen), rabbit monoclonal antibodies against phospho-AURKA Thr288 /AURKB Thr232 / AURKC Thr198 (Cell Signaling Technology), mouse monoclonal antibodies against cleaved PARP(Asp214) (BD Biosciences) and β-actin (Sigma-Aldrich) were obtained from the indicated suppliers.
Live cell imaging. Cells were seeded onto 24-well plates and imaged using a ECLIPSE-Ti inverted fluorescent microscope (Nikon) equipped with a SPOT BOOST TM EMCCD camera (Diagnostic Instrument) and a Chamlide TC temperature, humidity and CO 2 control system (LCI Live Cell Instrument). Data acquisition was performed at 5 min/frame.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed. and doxycycline for 72 h. The cells were then cultured in the absence of doxycycline. EGFP-positive cells were isolated by two rounds of fluorescent-activated cell sorting (Becton Dickinson, FACSAriaII) at 4 d and 11 d. Unless stated otherwise, cells were treated with the following reagents at the indicated final concentration: DCB (dihydrocytochalasin B, 10 μM, Sigma-Aldrich), MLN8237 (Selleck Chemicals LLC), nocodazole (0.1 μg/ml, Sigma-Aldrich), pan-caspase inhibitor Z-VAD(OMe)-FMK (10 μM, Enzo Life Sciences), MG132 (10 μM, Sigma-Aldrich) and ZM447439 (2 μM, Selleck Chemicals LLC). Fresh medium and drugs were replenished every 24 h.
Transfection and siRNAs. Stealth siRNAs targeting human AURKB was obtained from Invitrogen (HSS113646). Transfection of siRNA and plasmids was performed using Lipofectamine TM RNAiMAX (Invitrogen). Cell viability analysis and flow cytometry. Trypan blue analysis and flow cytometry analysis after propidium iodide staining were performed as described previously. 30 To analyze cleaved PARP with flow cytometry, cells were trypsinized, washed with PBS and fixed with ice cold 80% EtOH. The cells were then incubated with an antibody against cleaved PARP(Asp214) (BD Biosciences PharMingen) followed by incubation with a secondary antibody as instructed by the manufacturer. The cells were then stained with propidium iodide and analyzed with flow cytometry.
Antibodies and immunological methods. Immunoblotting was performed as previously described. 31 Mouse monoclonal © 2012 Landes Bioscience.
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